Skip to main content
. Author manuscript; available in PMC: 2018 Mar 12.
Published in final edited form as: Mod Pathol. 2010 May 14;23(8):1113–1126. doi: 10.1038/modpathol.2010.96

Figure 2. Overall survival of patients by diagnostic subgroups.

Figure 2

Figure 2

Overall survival of patients with acute myeloid leukemia or myelodysplastic syndrome with erythroid predominance. (a) Overall survival of patients in four diagnostic subgroups. (b) Comparison of overall survival between acute erythroid leukemia and acute myeloid leukemia with myelodysplasia-related changes and (P=0.005). (c) Comparison of overall survival between acute erythroid leukemia and therapy-related acute myeloid leukemia (P<0.0001). (d) Comparison of overall survival between acute erythroid leukemia and refractory anemia with excess blasts and recent/concurrent history of erythropoietin treatment for anemia.